Report error Found 10 Enz. Inhib. hit(s) with all data for entry = 13241
Affinity DataEC50: <1nMAssay Description:Table D: The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader ClarioStar Plus. The enzymatic reaction wa...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor [1-770,'NPG',771-1210,T790M](Human)
Celyn Therapeutics
US Patent
Celyn Therapeutics
US Patent
Affinity DataEC50: <1nMAssay Description:Table B: The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader ClarioStar Plus. The enzymatic reaction wa...More data for this Ligand-Target Pair
Affinity DataEC50: 3nMAssay Description:Table D: The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader ClarioStar Plus. The enzymatic reaction wa...More data for this Ligand-Target Pair
Affinity DataEC50: 3nMAssay Description:Table D: The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader ClarioStar Plus. The enzymatic reaction wa...More data for this Ligand-Target Pair
Affinity DataEC50: 3nMAssay Description:Table D: The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader ClarioStar Plus. The enzymatic reaction wa...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor [1-770,'NPG',771-1210,T790M](Human)
Celyn Therapeutics
US Patent
Celyn Therapeutics
US Patent
Affinity DataEC50: 3nMAssay Description:Table B: The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader ClarioStar Plus. The enzymatic reaction wa...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor [1-770,'NPG',771-1210,T790M](Human)
Celyn Therapeutics
US Patent
Celyn Therapeutics
US Patent
Affinity DataEC50: 3nMAssay Description:Table B: The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader ClarioStar Plus. The enzymatic reaction wa...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor [1-770,'NPG',771-1210,T790M](Human)
Celyn Therapeutics
US Patent
Celyn Therapeutics
US Patent
Affinity DataEC50: 3nMAssay Description:Table B: The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader ClarioStar Plus. The enzymatic reaction wa...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor [1-770,'NPG',771-1210,T790M](Human)
Celyn Therapeutics
US Patent
Celyn Therapeutics
US Patent
Affinity DataEC50: 3nMAssay Description:Table B: The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader ClarioStar Plus. The enzymatic reaction wa...More data for this Ligand-Target Pair
Affinity DataEC50: 3nMAssay Description:Table D: The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader ClarioStar Plus. The enzymatic reaction wa...More data for this Ligand-Target Pair




